After Setbacks, Confidence Grows In Likely Success For Sarepta’s Duchenne Gene Therapy

Contrasts With Pfizer Safety Concerns

 
• By Andrew McConaghie
  
Sarepta Building 2
The latest Phase II readout adds to growing data suggesting Sarepta's gene therapy could prove safe and effective. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip